Latest News

Glioblastoma patients treated with bevacizumab experience reduced cognitive function and quality of life, study suggests

Many glioblastoma patients treated with bevacizumab (AvastinŽ) have significant deterioration in neurocognitive function, symptoms and quality of life.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Covert and overt forms of sexism are equally damaging to working women

  • Retinoids may increase effectiveness of targeted therapies against high-risk leukemia

  • Air pollution linked to children's low academic achievement

  • Turning breath into words: New device unveiled to give paralysis victims a voice

  • Neurobiology: Light-activated learning

  • Glial cells use lipids to direct neuron organization in the spinal cord

  • Degenerating neurons respond to gene therapy treatment for Alzheimer's disease

  • Massive study reports challenges in reproducing published psychology findings

  • Four-day school week can improve academic performance, study finds

  • Cannabis and the brain

  •